Why Are patients With Heart Failure and Preserved Ejection Fraction Hospitalized? Data From I-PRESERVE

被引：0
|
作者：
Carson, Peter [1 ]
Anand, Inder [2 ]
Win, Sithu [2 ]
Zile, Michael [3 ,4 ]
Haas, Markus [5 ]
Little, William [6 ]
Miller, Alan [7 ]
Lopez-Sendon, Jose [8 ]
Teerlink, John [9 ,10 ]
White, Michel [11 ]
Komajda, Michel [12 ]
McKelvie, Robert S. [13 ]
McMurray, John J. [14 ]
Massie, Barry [9 ,10 ]
机构：
[1] Washington VA Med Cntr, Washington, DC USA
[2] Minneapolis VAMC, Cardiol, Minneapolis, MN USA
[3] Charleston VAMC, Cardiol, Charleston, SC USA
[4] MUSC, Charleston, SC USA
[5] Theresienkrankenhaus, Mannheim, Germany
[6] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[7] Univ Florida Shands, Jacksonville, FL USA
[8] Hosp Univ LePaz, Madrid, Spain
[9] Univ Calif San Francisco, San Francisco, CA 94143 USA
[10] San Francisco VA Med Ctr, San Francisco, CA USA
[11] Montreal Heart Cntr, Montreal, PQ, Canada
[12] Univ Paris, Pitie Salpetriere Hosp, F-75252 Paris, France
[13] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada
[14] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Rsch Cntr, Glasgow, Lanark, Scotland
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Heart failure; Ejection fraction;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15844
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mode of death in patients with heart failure and a preserved ejection fraction: results from irbesartan heart failure with preserved ejection fraction study (I-Preserve) trial
    Zile, M. R.
    Gaasch, W. H.
    Anand, I.
    Haass, M.
    Little, W. C.
    Miller, A.
    Lopez-Sendon, J.
    Teerlink, J. R.
    White, M.
    Carson, P. E.
    EUROPEAN HEART JOURNAL, 2009, 30 : 867 - 867
  • [2] Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial
    Zile, Michael R.
    Gaasch, William H.
    Anand, Inder S.
    Haass, Markus
    Little, William C.
    Miller, Alan B.
    Lopez-Sendon, Jose
    Teerlink, John R.
    White, Michel
    McMurray, John J.
    Komajda, Michel
    McKelvie, Robert
    Ptaszynska, Agata
    Hetzel, Scott J.
    Massie, Barry M.
    Carson, Peter E.
    CIRCULATION, 2010, 121 (12) : 1393 - 1405
  • [3] Predictors of outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in heart failure with preserved ejection fraction trial (I-PRESERVE)
    Carson, P. E.
    Komajda, M.
    Zile, M. R.
    Mckelvie, R.
    Mcmurray, J. J.
    Hetzel, S.
    Demets, D.
    Staiger, C.
    Ptaszynska, A.
    Massie, B. M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 865 - 865
  • [4] Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-PRESERVE)
    Komajda, Michel
    Carson, Peter E.
    Hetzel, Scott
    McKelvie, Robert
    McMurray, John
    Ptaszynska, Agata
    Zile, Michael R.
    DeMets, David
    Massie, Barry M.
    CIRCULATION-HEART FAILURE, 2011, 4 (01) : 27 - U73
  • [5] HEART FAILURE WITH PRESERVED EJECTION FRACTION: MORTALITY RISK POST FIRST HOSPITALIZATION - DATA FROM I-PRESERVE
    Carson, Peter E.
    Zile, Michael
    McMurray, John
    McKelvie, Robert
    Komajda, Michel
    Hetzel, Scott
    DeMets, David
    Staiger, Christoph
    Ptaszynska, Agata
    Massie, Barry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [6] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Lam, Carolyn S. P.
    Carson, Peter E.
    Anand, Inder S.
    Rector, Thomas S.
    Kuskowski, Michael
    Komajda, Michel
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Massie, Barry M.
    Kitzman, Dalane W.
    CIRCULATION-HEART FAILURE, 2012, 5 (05) : 571 - 578
  • [7] Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial
    McMurray, John J. V.
    Carson, Peter E.
    Komajda, Michel
    McKelvie, Robert
    Zile, Michael R.
    Ptaszynska, Agata
    Staiger, Christoph
    Donovan, J. Mark
    Massie, Barry M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (02) : 149 - 156
  • [8] Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Haass, Markus
    Kitzman, Dalane W.
    Anand, Inder S.
    Miller, Alan
    Zile, Michael R.
    Massie, Barry M.
    Carson, Peter E.
    CIRCULATION-HEART FAILURE, 2011, 4 (03) : 324 - 331
  • [9] The Relation of Quality of Life Score to Outcome in Heart Failure With Preserved Ejection Fraction: Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial (I-PRESERVE)
    Carson, Peter
    Komajda, Michel
    Zile, Michael
    Johnson, Ralph H.
    Hetzel, Scott
    Mckelvie, Robert
    McMurray, John
    Staiger, Christoph
    Ptaszynska, Agata
    Massie, Barry
    CIRCULATION, 2009, 120 (18) : S749 - S749
  • [10] MORBIDITY AND MORTALITY IN DIABETICS WITH HEART FAILURE AND A PRESERVED EJECTION FRACTION: RESULTS FROM THE I-PRESERVE TRIAL
    Win, Sithu
    Anand, Inderjit
    McMurray, John
    Zile, Michael
    McKelvie, Robert
    Komajda, Michel
    Massie, Barry
    Carson, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E706 - E706
12345